CHRO   $13.5  7.14% Market Closed

Channel Therapeutics Corporation
Total Cash 2.41M
totalCashPerShare 0.417
EBITDA
Total Debt 1.59M
quickRatio 0.863
currentRatio 0.934
Total Revenue
debtToEquity
Revenue/Share
ROA -4.12802
ROE
grossProfits
freeCashflow -6.49M
operatingCashflow -5.56M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.88M
forwardPE -0.58363634
floatShares 1.33M
sharesOutstanding 5.77M
sharesShort 18.79K
sharesShortPriorMonth 20.11K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.81%
heldPercentInstitutions 0.10%
Short Ratio help_outline 0.12%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -0.031
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -9.79M
trailingEps -1.68%
forwardEps -1.10%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.55
institutionsCount 8
lastUpdated Nov. 2, 2024, 7:09 a.m.